Dr. Lamouille's Publications

For a more complete list of publications, visit the following publication sites: PubMed

Pridham KJ, Shah F, Hutchings KR, Sheng KL, Guo S, Liu M, Kanabur P, Lamouille S, Lewis G, Morales M, Jourdan J, Grek CL, Ghatnekar GG, Varghese R, Kelly DF, Gourdie RG, Sheng Z. Connexin 43 confers chemoresistance through activating PI3K. Oncogenesis. 2022 Jan 12;11(1):2. doi: 10.1038/s41389-022-00378-7. PMID: 35022385; PMCID: PMC8755794.

King DR, Sedovy MW, Leng X, Xue J, Lamouille S, Koval M, Isakson BE, Johnstone SR. Mechanisms of Connexin Regulating Peptides. Int J Mol Sci. 2021 Sep 22;22(19):10186. doi: 10.3390/ijms221910186. PMID: 34638526; PMCID: PMC8507914. 

Roberts R, Smyth JW, Will J, Roberts P, Grek CL, Ghatnekar GS, Sheng Z, Gourdie RG, Lamouille S, Foster EJ. Development of PLGA nanoparticles for sustained release of a connexin43 mimetic peptide to target glioblastoma cells. Mater Sci Eng C Mater Biol Appl. 2020 Mar;108:110191. 

Sheng KL, Pridham KJ, Sheng Z, Lamouille S, Varghese RT. (2019). Functional Blockade of the Small GTPase RAN Inhibits Glioblastoma Viability. Frontiers in Oncology 8: 662.

Katsuno Y, Qin J, Oses-Prieto J, Wang H, Jackson-Weaver O, Zhang T, Lamouille S, Wu J, Burlingame A, Xu J, Derynck R. (2018). Arginine methylation of SMAD7 by PRMT1 in TGF-β-induced epithelial-mesenchymal transition and epithelial stem-cell generation. Journal of Biological Chemistry 293: 13059-72.

James CC, Zeitz MJ, Calhoun PJ, Lamouille S, Smyth JW. (2018). Altered translation initiation of Gja1 limits gap junction formation during epithelial-mesenchymal transition. Molecular Biology of the Cell 29(7): 773-880.

Murphy SF, Varghese RT, Lamouille S, Guo S, Pridham KJ, Kanabur P, Osimani AM, Sharma S, Jourdan J, Rodgers CM, Simonds GR, Gourdie RG, Sheng Z. (2016). Connexin 43 Inhibition Sensitizes Chemoresistant Glioblastoma Cells to Temozolomide. Cancer Research 76(1): 139-49.

Smyth JW, Zhang SS, Sanchez JM, Lamouille S, Vogan JM, Hesketh GG, Hong T, Tomaselli GF, Shaw RM. (2014). A 14-3-3 mode-1 binding motif initiates gap junction internalization during acute cardiac ischemia. Traffic 15(6): 684-699.

Lamouille S, Xu J, Derynck R. (2014). Molecular mechanisms of epithelial-mesenchymal transition. Nature Reviews Molecular Cell Biology 15: 178-96.

Lamouille S, Subramanyam D, Blelloch R, Derynck R. (2013). Regulation of epithelial-mesenchymal and mesenchymal-epithelial transitions by microRNAs. Current Opinion in Cell Biology 25(2).

Lamouille S, Subrmanyam D, Blelloch R, Deyrnck R. (2013). Regulation of epithelial–mesenchymal and mesenchymal–epithelial transitions by microRNAs. Current Opinion in Cell Biology 25(2): 200-07.

Katsuno Y, Lamouille S, Derynck R. (2013). TGF-β signaling and epithelial-mesenchymal transition in cancer progression. Current Opinion in Oncology 25(1).

Lamouille S, Connolly E, Smyth JW, Akhurst RJ, Derynck R. (2012). TGF-β induced activation of mTOR complex 2 drives epithelial-mesenchymal transition and cell invasion. Journal of Cell Science 1(125).

Lamouille S, Connonlly E, Smyth JW, Akhurst RJ, Derynck R. (2012). TGF-β-induced activation of mTOR complex 2 drives epithelial-mesenchymal transition and cell invasion. Journal of Cell Science 125: 1259-73.

Subramanyam D, Lamouille S, Judson RL, Liu JY, Bucay N, Derynck R, Blelloch R. (2011). Multiple targets of miR-302 and miR-372 promote reprogramming of human fibroblasts to induced pluripotent stem cells. Nature Biotechnology 29(5): 443-8.

Lamouille S, Derynck R. (2011). Emergence of the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin axis in transforming growth factor-β-induced epithelial-mesenchymal transition. Cells Tissues Organs 193: 8-22.

Lamouille S, Derynck R. (2009). Oncogene and tumour suppressor: the two faces of SnoN. The EMBO Journal 28(22): 3459-60.

Liu C, Xu P, Lamouille S, Xu J, Derynck R. (2009). TACE-mediated ectodomain shedding of the type I TGF-beta receptor downregulates TGF-beta signaling. Molecular Cell 35(1): 26-36.

Xu J, Lamouille S, Derynck R. (2009). TGF-beta-induced epithelial to mesenchymal transition. Cell Research 19: 156-72.

David L, Mallet C, Vailhe B, Lamouille S, Feige JJ, Bailly S. (2007). Activin receptor-like kinase 1 inhibits human microvascular endothelial cell migration: potential roles for JNK and ERK. Journal of Cellular Physiology 213(2): 484-9.

Lamouille S, Derynck R. (2007). Cell size and invasion in TGF-beta-induced epithelial to mesenchymal transition is regulated by activation of the mTOR pathway. Journal of Cell Biology 178(3): 437.

Lamouille S, Mallet C, Feige JJ, Bailly S. (2002). Activin receptor-like kinase 1 is implicated in the maturation phase of angiogenesis. Blood 100(13): 4495-501.